BMO Capital Markets Increases Maricann Group (CNSX:MARI) Price Target to $5.75

Maricann Group (CNSX:MARI) had its target price upped by equities researchers at BMO Capital Markets from $5.50 to $5.75 in a report released on Friday,BayStreet.CA reports.

Maricann Group Stock Performance

Maricann Group has a 1-year low of $0.87 and a 1-year high of $3.60.

About Maricann Group

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients.